ATE416783T1 - Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen - Google Patents
Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomenInfo
- Publication number
- ATE416783T1 ATE416783T1 AT03708393T AT03708393T ATE416783T1 AT E416783 T1 ATE416783 T1 AT E416783T1 AT 03708393 T AT03708393 T AT 03708393T AT 03708393 T AT03708393 T AT 03708393T AT E416783 T1 ATE416783 T1 AT E416783T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- chorionic gonadotropin
- human chorionic
- endometriosis
- symptoms
- Prior art date
Links
- 102000011022 Chorionic Gonadotropin Human genes 0.000 title abstract 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 title abstract 2
- 201000009273 Endometriosis Diseases 0.000 title abstract 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 title abstract 2
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 208000004483 Dyspareunia Diseases 0.000 abstract 1
- 208000000450 Pelvic Pain Diseases 0.000 abstract 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2003/001066 WO2004069271A1 (en) | 2003-02-07 | 2003-02-07 | Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE416783T1 true ATE416783T1 (de) | 2008-12-15 |
Family
ID=32843795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03708393T ATE416783T1 (de) | 2003-02-07 | 2003-02-07 | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060258568A1 (de) |
| EP (1) | EP1596881B1 (de) |
| AT (1) | ATE416783T1 (de) |
| AU (1) | AU2003212569A1 (de) |
| CA (1) | CA2515297A1 (de) |
| DE (1) | DE60325275D1 (de) |
| WO (1) | WO2004069271A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080306034A1 (en) * | 2007-06-11 | 2008-12-11 | Juneau Biosciences, Llc | Method of Administering a Therapeutic |
| US20120265129A1 (en) * | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
| US20150290293A1 (en) * | 2011-04-15 | 2015-10-15 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using hcg |
| US8680086B2 (en) * | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
| MX2015004940A (es) | 2012-10-18 | 2015-12-09 | Neuralight Hd Llc | Tratamiento de depresion y ptsd. |
| CN107206057A (zh) * | 2014-11-12 | 2017-09-26 | 纽瑞莱特Hd有限公司 | 用hcg处理和治疗慢性疼痛的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196123A (en) * | 1978-11-20 | 1980-04-01 | Eugenia Rosemberg | Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same |
| ZA845550B (en) * | 1983-08-09 | 1986-03-26 | American Home Prod | Treatment of endometriosis |
| EP1022027A1 (de) * | 1999-01-22 | 2000-07-26 | Applied Research Systems ARS Holding N.V. | Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose |
| US6284262B1 (en) * | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
| EP1176976B2 (de) * | 1999-05-07 | 2015-10-21 | Laboratoires Serono SA | Gonadotrophine |
| EP1425032A2 (de) * | 2001-09-12 | 2004-06-09 | Applied Research Systems ARS Holding N.V. | Verwendung von humanem choriongonadotropin (hcg) zur regulierten hyperstimulation der eierstöcke |
-
2003
- 2003-02-07 AT AT03708393T patent/ATE416783T1/de not_active IP Right Cessation
- 2003-02-07 DE DE60325275T patent/DE60325275D1/de not_active Expired - Fee Related
- 2003-02-07 CA CA002515297A patent/CA2515297A1/en not_active Abandoned
- 2003-02-07 WO PCT/IB2003/001066 patent/WO2004069271A1/en not_active Ceased
- 2003-02-07 AU AU2003212569A patent/AU2003212569A1/en not_active Abandoned
- 2003-02-07 EP EP03708393A patent/EP1596881B1/de not_active Expired - Lifetime
- 2003-02-07 US US10/544,856 patent/US20060258568A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1596881A1 (de) | 2005-11-23 |
| DE60325275D1 (de) | 2009-01-22 |
| CA2515297A1 (en) | 2004-08-19 |
| EP1596881B1 (de) | 2008-12-10 |
| AU2003212569A1 (en) | 2004-08-30 |
| AU2003212569A8 (en) | 2004-08-30 |
| WO2004069271A1 (en) | 2004-08-19 |
| US20060258568A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
| ATE368034T1 (de) | Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase | |
| DE602005011279D1 (de) | Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen | |
| DE60332433D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| DE60332604D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
| DE60011100D1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen | |
| GB0402137D0 (en) | Novel compounds | |
| ATE416177T1 (de) | Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer | |
| DE60204951D1 (de) | Ccr5 antagonisten verwendbar für die behandlung von aids | |
| NL1025873A1 (nl) | Doseringsvormen en wijzen van behandeling met vegfr-remmers. | |
| ATE419845T1 (de) | Il-8-rezeptor-antagonisten | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| GB0402138D0 (en) | Novel compounds | |
| DE602004023762D1 (de) | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren | |
| BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
| DE60101559D1 (de) | Benutzung von comt-inhibitoren als analgetika | |
| DE60325275D1 (de) | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen | |
| NO20065859L (no) | Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser | |
| EA200300844A1 (ru) | Использование ингибиторов il-18 для лечения и/или профилактики заболевания сердца | |
| DE60334556D1 (de) | Chorionic gonadotropin zur Behandlung des chronischen Schmerzsyndroms des Beckens | |
| EA200401423A1 (ru) | Пиперазинбензотиазолы, используемые в качестве средств для лечения церебральных ишемических расстройств или расстройств цнс | |
| DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |